Being present: oncologists' role in promoting advanced cancer patients' illness understanding

Simon M Cohen, Renee C Maciejewski, Manish A Shah, Kelly M Trevino, Megan J Shen, Paul K Maciejewski, Holly G Prigerson, Simon M Cohen, Renee C Maciejewski, Manish A Shah, Kelly M Trevino, Megan J Shen, Paul K Maciejewski, Holly G Prigerson

Abstract

Realistic illness understanding is essential to an advanced cancer patient's ability to make informed medical decisions at the end of life. This study sought to determine whether advanced cancer patients better understood the late stage of their cancer if an oncologist, compared to other members of the care team, was present to discuss their scan results. Data were derived from a multi-institutional, longitudinal cohort study of patients recruited between 2010 and 2015. Patients (n = 209) with late-stage cancers (metastatic cancers that progressed after at least one chemotherapy regimen) were interviewed before and after clinic visits in which scan results were discussed. Patients reported pre- and postvisit if their cancer was at a late stage. Postvisit, patients reported if they discussed scan results with an oncologist or another oncology provider (i.e., oncology fellow, oncology resident, nurse practitioner, nurse, physician's assistant, or other). Logistic regression analysis was used to determine if the presence of an oncologist during scan results discussions differentially predicted the patients' likelihood of postvisit late-stage illness understanding (LSIU). Propensity weighting was used to correct for sociodemographic imbalances between groups, and previsit LSIU and the presence of multiple providers were controlled for in the logistic regression analyses. After propensity-weighted adjustment and controlling for previsit LSIU and the presence of multiple providers, patients were 2.6 times more likely (AOR = 2.6; 95% CI = 1.2, 6.0; P = 0.021) to report that their disease was late stage if an oncologist was present for the scan results discussion compared to if an oncologist was absent. The presence of an oncologist during scan results discussions was associated with a higher likelihood of patients acknowledging being in a late stage of their disease. These results suggest that oncologist involvement in scan results discussions is associated with advanced cancer patients having better prognostic understanding.

Keywords: Cancer; end of life; illness understanding; late stage; oncologist; prognosis.

© 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Flow diagram of patients.

References

    1. Prigerson, H. G. 1992. Socialization to dying ‐ social determinants of death acknowledgment and treatment among terminally ill geriatric‐patients. J. Health Soc. Behav. 33:378–395.
    1. Weeks, J. C. , Catalano P. J., Cronin A., Finkelman M. D., Mack J. W., Keating N. L., et al. 2012. Patients' expectations about effects of chemotherapy for advanced cancer. N. Engl. J. Med. 367:1616–1625.
    1. Weeks, J. C. , Cook E. F., O'Day S. J., Peterson L. M., Wenger N., Reding D., et al. 1998. Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709–1714.
    1. Mack, J. W. , Weeks J. C., Wright A. A., Block S. D., and Prigerson H. G.. 2010. End‐of‐life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J. Clin. Oncol. 28:1203–1208.
    1. Wright, A. A. , Zhang B. H., Keating N. L., Weeks J. C., and Prigerson H. G.. 2014. Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ 348:10.
    1. Wright, A. A. , Zhang B. H., Ray A., Mack J. W., Trice E., Balboni T., et al. 2008. Associations between end‐of‐life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300:1665–1673.
    1. Epstein, A. S. , Prigerson H. G., O'Reilly E. M., and Maciejewski P. K.. 2016. Discussions of life expectancy and changes in illness understanding in patients with advanced cancer. J. Clin. Oncol. 34:2398–2403.
    1. Enzinger, A. C. , Zhang B. H., Schrag D., and Prigerson H. G.. 2015. Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer. J. Clin. Oncol. 33:3809–+.
    1. Milgram, S. 1963. Behavioral‐study of obedience. J. Abnorm. Psychol. 67:371.
    1. Burger, J. M. 2009. Replicating Milgram would people still obey today? Am. Psychol. 64:1–11.
    1. Cialdini, R. B. 2007. Influence: the psychology of persuasion. Collins, New York.
    1. Stuart, E. A. 2010. Matching methods for causal inference: a review and a look forward. Stat. Sci. 25:1–21.
    1. Mack, J. W. , Cronin A., Keating N. L., Taback N., Huskamp H. A., Malin J. L., et al. 2012. Associations between end‐of‐life discussion characteristics and care received near death: a prospective cohort study. J. Clin. Oncol. 30:4387–4395.
    1. Fridman, I. , Epstein A. S., and Higgins E.. 2015. Appropriate use of psychology in patient‐physician communication: Influencing wisely. JAMA Oncol. 1:725–726.
    1. Mack, J. W. , Walling A., Dy S., Antonio A. L., Adams J., Keating N. L., et al. 2015. Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer. Cancer 121:1891–1897.
    1. Thomas, R. A. , Curley B., Wen S., Zhang J., Abraham J., and Moss A. H.. 2015. Palliative care training during fellowship: a national survey of U.S. hematology and oncology fellows. J. Palliat. Med. 18:747–751.
    1. Coyle, N. , Manna R., Shen M., Banerjee S. C., Penn S., Pehrson C., et al. 2015. Discussing death, dying, and end‐of‐life goals of care: a communication skills training module for oncology nurses. Clin. J. Oncol. Nurs. 19:697–702.
    1. Bach, P. B. , Schrag D., and Begg C. B.. 2004. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA 292:2765–2770.
    1. Lamont, E. B. , Schilsky R. L., He Y., Muss H., Cohen H. J., Hurria A., et al. 2015. Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802). J. Natl Cancer Inst. 107:336.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren